Atlas Trials

Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM

Clinical trial NCT01958528 · COMPLETED

Trial details

NCT number
NCT01958528
Sponsor
Abramson Cancer Center at Penn Medicine
Status
COMPLETED
Study type
OBSERVATIONAL
a Diagnosis of MGUS or SMM by IMWG Criteria
Start date
2013-05-23
Primary completion
2019-01-11
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.